Clinical Trials Browser

Phase 1 × INDUSTRY × axatilimab × Clear all

NCT03238027 2024-05-17

A Phase 1 Study to Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid Tumors

Phase 1 Completed

Neoplasm Metastasis